Bora vs Medigen Vaccine Biologics: monthly revenue

Monthly revenue and year-on-year change for Bora (6472) and Medigen Vaccine Biologics (6547) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Bora ━ Medigen Vaccine Biologics

0%+417%-30%25/1026/0126/0426/0726/10

Monthly revenue history

MonthBoraYoYMedigen Vaccine BiologicsYoY
Oct 2026NT$1.99 billion+15.9%NT$100 million+43.2%
Sep 2026NT$2.33 billion+35.1%NT$207.2 million+98.8%
Aug 2026NT$2.18 billion+59.2%NT$236.4 million+416.9%
Jul 2026NT$1.9 billion+5.8%NT$47.4 million-15.3%
Jun 2026NT$2.3 billion+39.2%NT$41.6 million-26.4%
May 2026NT$2.11 billion+40.2%NT$34.8 million-25.0%
Apr 2026NT$1.48 billion-27.5%NT$38.7 million-7.9%
Mar 2026NT$1.53 billion+6.3%NT$43.5 million-4.6%
Feb 2026NT$1.33 billion-23.2%NT$25.3 million-25.2%
Jan 2026NT$1.14 billion-30.2%NT$37.1 million+3.2%
Dec 2025NT$1.66 billion-16.6%NT$42.4 million+14.5%
Nov 2025NT$1.5 billion-10.8%NT$34.8 million-1.8%
Oct 2025NT$1.72 billion-17.8%NT$69.8 million+23.9%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16